Economic Evaluation of Tirbanibulin for the Treatment of Actinic Keratosis in Scotland.

ABSTRACT:

Background

Tirbanibulin 1% ointment is a new treatment for actinic keratosis (AK) on the face or scalp. A health economic model was developed as part of a submission to the Scottish Medicines Consortium to evaluate the cost-effectiveness of tirbanibulin compared to the most frequently prescribed treatments.

Methods

A decision tree approach was used to calculate the costs and benefits of different treatment strategies for AK on the face or scalp over a one-year time horizon. Data on the relative efficacy of treatments, which were based on the probability of complete clearance of AK, were obtained from a network meta-analysis. Sensitivity and scenario analyses were performed to determine the robustness of the model results.

Results

Tirbanibulin is estimated to be cost s

SUBMITTER: Dymond A 

PROVIDER: S-EPMC10170011 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature